WardBlackLaw, protecting people's right
Janet Ward Black, Attorney at Law
Our Firm
What We Do
Right to Know
Community
Helpful Links
Get Started
Asbestos Photo Gallery
Contact
- Personal Injury
- Medical Malpractice
- Harmful Drugs/Products
- Nursing Home Litigation
- Workers' Compensation
- Asbestos
- Car Wrecks
- Legal Malpractice
- Inadequate Security
- Premises Liability
- Enviromental Accidents
If you've been seriously injured, we can help. Please call 1-877-256-1214, or contact us through the form below. Thank you.
Free Case Review!Trasylol
Trasylol manufactured by Bayer is a widely used medicine used in heart surgeries to reduce blood loss. On February 8, 2006 the FDA issued a public health warning to doctors and patients that two new studies have linked Trasylol to an increased risk for serious side effects including kidney problems, heart attacks and strokes.
In 60% of all heart bypass surgeries Trasylol is used to reduce blood loss. The NEJM study found that Trasylol increased the risk of myocardial infarction by 48%, heart failure by 109%, and stroke by 181%. None of the alternative drugs available that could be used in heart bypass surgeries to reduce blood loss are associated with increased renal, cardiac, or cerebral events.
The link for the public health warning is: http://www.fda.gov/bbs/topics/news/2006/NEW01311.html
Contact Ward Black Law if you or a loved one have suffered from serious injury after heart bypass surgery at 1-800-531-9191 for a free consultation or contact us via email.
Sources:
- Study Questions Safety of Heart Drug, by Alicia Chang, The Associated Press. Published 1/25/06. Accessed 2/01/06 from ABC News.
- FDA Issues Public Health Advisory for Trasylol. Accessed 2/08/06 from the Food and Drug Administration.
- FDA Public Health Advisory, Aprotinin Injection (marketed as Trasylol) on September 29, 2006, from the Food and Drug Administration.
Back to Defective Products & Medical Devices
Back to What We Do
